D. body mass index (BMI) or insulin sensitivity (SI) in either adipose or muscle. However, adipose ATGL protein levels were inversely correlated with BMI (r=0.64, p<0.02), and positively correlated with SI(r=0.67, p<0.02). In muscle, ATGL mRNA demonstrated a strong positive relationship with carnitine palmitoyltransferase I mRNA (r=0.82, p<0.0001), and the adiponectin receptors AdipoR1 mRNA (r=0.71, p<0.0001), and AdipoR2 mRNA (r=0.74, p<0.0001). Muscle CGI-58 mRNA was inversely correlated with intramyocellular triglyceride in both type 1 (r=0.35, p<0.05) and type 2 (r=0.40, p<0.05) fibers. Exercise training resulted in increased muscle ATGL and pioglitazone increased adipose ATGL by 31% (p<0.05). Pioglitazone also increased ATGL in adipocytes. == Conclusions == Adipose ATGL protein is decreased with insulin resistance and obesity, and muscle ATGL mRNA is associated with markers of fatty acid oxidation in muscle, as is CGI-58. The regulation of ATGL and CGI-58 have important implications for the control of lipotoxicity. Keywords:CGI-58, muscle fatty acid oxidation, lipotoxicity, exercise, PPAR == INTRODUCTION == The disruption of the balance among lipid synthesis, uptake and utilization is critical in the development of metabolic diseases such as insulin resistance and type 2 diabetes (T2D) [1,2]. Adipose tissue in mammals is the main source for energy storage and retrieval in the form of triacylglycerol (TAG). Hydrolysis of TAG by activation of lipolytic enzymes results in free fatty acid (FFA) release into the circulation for use as an energy substrate, primarily by muscle. Muscle is an important target tissue in insulin resistance, and an important defect in the muscle of insulin resistant subjects is the accumulation of triglyceride, due to either increased uptake or decreased oxidation, leading to the generation of diacylglycerol, ceramide, and other factors that impair insulin action. Adipose triglyceride lipase (ATGL) catalyzes the first, rate-limiting step in TAG lipolysis, followed by additional lipolytic action by hormone sensitive lipase [3,4] and the release of FFA was decreased in 3T3-L1 cells treated with siRNA against ATGL [5]. Deletion of ATGL in mice caused weight gain and increased adipose mass, along with increased muscle glucose uptake due to an inability to use muscle lipid as fuel [6,7]. Full ATGL activity requires interaction with the activator protein CGI-58 [3,8-10]. CGI-58 knockout mice demonstrate an impaired lipolysis phenotype just like the ATGL knockout mouse [11]. The regulation of ATGL at the level of transcription is not well characterized, although ATGL mRNA expression is regulated by some nutritional and hormonal factors such as fasting, glucocorticoids, insulin, and leptin [7]. Several studies have shown that ATGL mRNA is increased by rosiglitazone in adipose tissue of rodents [12,13] as well as in 3T3-L1 adipocytes [14]. PPAR-specific antagonist and siRNA-mediated inhibition of PPAR inhibited rosiglitazone induced ATGL mRNA expressions, indicating a role for ATGL in triglyceride metabolism mediated by PPAR [14]. In addition to the role Cefradine of ATGL in adipose tissue lipolysis, this enzyme Rabbit Polyclonal to C-RAF (phospho-Ser301) likely plays an important role in muscle. ATGL deficient mice showed significant TAG accumulation in skeletal muscle and less fatty acid oxidation measured with respiratory quotient, along with a shift to carbohydrate over fat as an energy source [5]. In addition, ATGL expression was decreased in skeletal muscle of obese, insulin resistant mice and rats [15], and ATGL overexpression in myotubes increased fatty acid oxidation and ceramide contents, suggesting a critical role of ATGL in triglyceride metabolism and storage in muscle. As suggested by Zimmermann et al [3], FFA is likely taken up by muscle and Cefradine initially re-esterified into TAG, and the lipolysis of the intramyocellular TAG stores is a critical step in supplying muscle with the FFA fuel that is needed for oxidation and energy Cefradine needs. The precise role and degree of regulation of ATGL and CGI-58 in humans is not well known. There are several studies involving ATGL in humans and variable results have been obtained. Depending on the study, adipose ATGL mRNA was either decreased, increased, or unchanged with obesity, and ATGL protein either unchanged or decreased [16-19]. Studies in human muscle found that ATGL was associated with type 1 muscle fibers [20], and may be upregulated by endurance exercise training [20]. There are no data that related human ATGL and CGI-58 to insulin sensitivity, or examine the relationship between ATGL and CGI-58. Here, we report the relationship of muscle and adipose ATGL and CGI-58 with obesity, insulin sensitivity, and markers of fatty acid oxidation. To further understand the regulation of ATGL and CGI-58, we examined the influence of pioglitazone and exercise training on gene expression. == METHODS == == Human subjects and tissues == The adipose tissue and muscle samples were obtained from three different groups of subjects. For each group, all subjects signed consent forms that were approved by the local.